Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease
出版年份 2019 全文链接
标题
Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease
作者
关键词
-
出版物
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-10
DOI
10.1038/s41418-019-0341-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
- (2018) Reka P. Toth et al. Frontiers in Immunology
- MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
- (2017) Isabel Jaco et al. MOLECULAR CELL
- Age-dependent Changes in the Articular Cartilage and Subchondral Bone of C57BL/6 Mice after Surgical Destabilization of Medial Meniscus
- (2017) Henry Huang et al. Scientific Reports
- Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling
- (2016) Karolina Slowicka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The TBK1-binding domain of optineurin promotes type I interferon responses
- (2016) Netra Pal Meena et al. FEBS LETTERS
- Measles virus nucleocapsid protein increases osteoblast differentiation in Paget’s disease
- (2016) Jumpei Teramachi et al. JOURNAL OF CLINICAL INVESTIGATION
- Men and mice: Relating their ages
- (2016) Sulagna Dutta et al. LIFE SCIENCES
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- Cellular Functions of Optineurin in Health and Disease
- (2016) Karolina Slowicka et al. TRENDS IN IMMUNOLOGY
- Visual impairment in an optineurin mouse model of primary open-angle glaucoma
- (2015) Henry C. Tseng et al. NEUROBIOLOGY OF AGING
- Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis
- (2015) A. A. Al Nofal et al. OSTEOPOROSIS INTERNATIONAL
- Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations
- (2015) Bethany A. Herbert et al. PLoS One
- Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget’s Disease
- (2015) Rami Obaid et al. Cell Reports
- RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
- (2014) Christopher P. Dillon et al. CELL
- Genetics of Paget’s Disease of Bone
- (2014) Stuart H. Ralston et al. Current Osteoporosis Reports
- Increased IL-6 Expression in Osteoclasts Is Necessary But Not Sufficient for the Development of Paget's Disease of Bone
- (2013) Jumpei Teramachi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation
- (2013) Yan Xiu et al. JOURNAL OF CLINICAL INVESTIGATION
- Optineurin Insufficiency Impairs IRF3 but Not NF- B Activation in Immune Cells
- (2013) I. Munitic et al. JOURNAL OF IMMUNOLOGY
- NF-κB signaling and bone resorption
- (2013) Y. Abu-Amer OSTEOPOROSIS INTERNATIONAL
- Autophagy regulates TNFα-mediated joint destruction in experimental arthritis
- (2012) Neng-Yu Lin et al. ANNALS OF THE RHEUMATIC DISEASES
- Mutant p62P392LStimulation of Osteoclast Differentiation in Paget's Disease of Bone
- (2011) Kumaran Sundaram et al. ENDOCRINOLOGY
- RANKL/RANK—beyond bones
- (2011) Reiko Hanada et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone
- (2010) Omar M E Albagha et al. NATURE GENETICS
- Myosin VI and Optineurin Are Required for Polarized EGFR Delivery and Directed Migration
- (2010) Margarita V. Chibalina et al. TRAFFIC
- Paget’s Disease of Bone: Histologic Analysis of 754 Patients
- (2008) Sebastian Seitz et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More